OUTLOOK THERAPEUTICS

LIVE

Serial Number

97478024

Owner

Outlook Therapeutics, Inc.

Attorney

Kelley B. Harrington

Filing Date

Jun 27, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

OUTLOOK THERAPEUTICS Trademark

Serial Number: 97478024

OUTLOOK THERAPEUTICS is a trademark filed by Outlook Therapeutics, Inc. on June 27, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Outlook Therapeutics, Inc.

485 Route 1 South, Building F, Suite 320
Iselin, NJ 08830

Entity Type: 03

Legal Representation

Attorney of Record

Kelley B. Harrington

410 trademarks filed View all →

Correspondence Address

Kelley B. Harrington Cooley LLP

1299 Pennsylvania Ave, NW, Suite 700

ATTN: IP Docketing Department

Washington, DC 20004-2400

United States

Trademark Details

Filing Date

June 27, 2022

Registration Date

Not Registered

Published for Opposition

May 16, 2023

Goods & Services

Pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 13, 2026 EXRA

SOU EXTENSION 5 GRANTED

Mar 12, 2026 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 12, 2026 AITU

SOU EXTENSION 5 FILED

Oct 14, 2025 EXT5

SOU TEAS EXTENSION RECEIVED

Oct 14, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 11, 2025 EXRA

SOU EXTENSION 4 GRANTED

Apr 10, 2025 EX4G

SOU EXTENSION 4 FILED

Apr 10, 2025 EXT4

SOU TEAS EXTENSION RECEIVED

Apr 10, 2025 EEXT

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Mar 19, 2025 EWAF

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 19, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 19, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 19, 2025 REAP

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 3, 2025 EXRA

SOU EXTENSION 3 GRANTED

Dec 24, 2024 EX3G

SOU EXTENSION 3 FILED

Dec 23, 2024 EXT3

SOU TEAS EXTENSION RECEIVED

Dec 23, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 28, 2024 EXRA

SOU EXTENSION 2 GRANTED

Jun 28, 2024 EX2G

SOU EXTENSION 2 FILED

Jun 28, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Jun 28, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 11, 2024 EXRA

SOU EXTENSION 1 GRANTED

Jan 9, 2024 EX1G

SOU EXTENSION 1 FILED

Jan 9, 2024 EXT1

SOU TEAS EXTENSION RECEIVED

Jan 9, 2024 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 11, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 16, 2023 NPUB

PUBLISHED FOR OPPOSITION

May 16, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 26, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 12, 2023 CNSA

EXAMINER'S AMENDMENT ENTERED

Apr 12, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 12, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

Apr 12, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

Apr 12, 2023 CNEA

ASSIGNED TO EXAMINER

Apr 10, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 14, 2022 NWOS

NEW APPLICATION ENTERED

Jun 30, 2022 NWAP

Related Trademarks

More from this Owner

OUTLOOK THERAPEUTICS

LYTENAVA

Serial #97831497

LYTENAVA NAVIGATOR

LYTENAVA SPOTLYTE

More in Same Class

BIOBIM